Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer.
Wound complications after obstetric anal sphincter injuries.
Chemistry, Clinical
Financing, Personal
Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104).
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104).
Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104). J Transl Med. 2012 Dec 10; 10:246.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Biopsy
Cell Line, Tumor
Enzyme Inhibitors
Extracellular Signal-Regulated MAP Kinases
Farnesyltranstransferase
Female
HSP40 Heat-Shock Proteins
Humans
Interferon-gamma
Male
Melanoma
Middle Aged
Neoplasm Staging
Phosphorylation
Proto-Oncogene Proteins c-akt
Quinolones
Signal Transduction
Skin Neoplasms
T-Lymphocytes
Treatment Outcome
authors with profiles
Thomas Gajewski